The global pharmaceutical packaging equipment market is estimated to exceed US$ 10.2 billion in 2023 to US$ 28.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 12% during the forecast period from 2024 to 2032.
Packaging is a crucial element in the pharmaceutical industry, serving essential functions related to consumer protection and the safe and effective delivery of medications. It plays a critical role in dosing, dispensing, and administering pharmaceutical products, encompassing a variety of equipment for gas, liquid, semi-solid, and solid packaging. The packaging of pharmaceutical products, including blister packaging, tablet packaging, and liquid packaging, is vital for preserving the efficacy of medications and combating external elements that could compromise the products.
Expanding Pharmaceutical Industry
The pharmaceutical industry is experiencing rapid expansion in developing countries, driven by increased healthcare spending, population growth, and evolving lifestyles. This growth is also fueled by the rising demand for medications to address age-related and chronic illnesses, leading to a surge in pharmaceutical consumption globally. Notably, the most relevant pharmaceutical categories include cholesterol-lowering, antidepressant, antihypertensive, and antidiabetic drugs. According to IQVIA, the use of medications, measured in defined daily doses, has increased by 36% over the past decade, primarily due to improved access to medicines.
The majority of medications, approximately 51%, are consumed orally in the form of tablets or capsules, typically packaged in blister packs or plastic pharmaceutical bottles. Other forms of oral medication intake include powders, pastels, and liquids. This positive growth in the pharmaceutical industry in developing nations is driving an increased demand for pharmaceutical packaging.
This is because packaging plays a crucial role in maintaining the quality, safety, and effectiveness of pharmaceutical products. Furthermore, the adoption of innovative drug delivery systems, such as prefilled syringes and inhalers, is also contributing to the demand for specialized packaging solutions in the pharmaceutical packaging equipment market.
Strict Regulatory Requirement
Regulatory standards and guidelines play a crucial role in ensuring the safety, effectiveness, and intactness of pharmaceutical packaging. These regulations, enforced by regulatory bodies globally, impose stringent criteria concerning packaging materials, labeling, and product traceability. Their primary objective is to prevent contamination, ensure accurate dosing, and provide precise product information to consumers. However, these requirements can present challenges for market growth.
The pharmaceutical industry faces significant impacts from regulatory changes, particularly in clinical trials. More stringent guidelines necessitate companies to conduct more extensive and rigorous trials to validate the safety and efficacy of their drugs. This involves recruiting larger participant pools, conducting lengthier trials, and gathering more comprehensive data. While these measures are essential for ensuring patient safety, they also impose substantial time and financial burdens on pharmaceutical firms.
Consequently, meeting these regulatory demands can be arduous and costly, particularly for small and medium-sized enterprises. The necessity for compliance can lead to product launch delays and significantly affect production costs within the pharmaceutical packaging equipment market.
Technological Advancement
Technological advancements are pivotal in propelling the pharmaceutical packaging market forward. Automation, robotics, and smart packaging technologies are instrumental in boosting efficiency, reducing errors, and improving traceability throughout the packaging process. For instance, the incorporation of track-and-trace systems aids pharmaceutical companies in adhering to serialization regulations and verifying the authenticity of products within the supply chain.
Furthermore, the adoption of smart packaging technologies has been on the upswing. This includes the utilization of RFID (Radio-Frequency Identification), QR codes, and sensors to enable real-time monitoring of pharmaceutical products across the supply chain. Smart packaging contributes to improved traceability and assists in upholding product quality.
Many pharmaceutical companies are embracing automation strategies to enhance efficiency in pharmaceutical packaging. As per the Association for Packaging and Processing Technologies, nearly 50% of pharmaceutical companies have integrated automation into their packaging processes. The growth in small-batch pharmaceuticals and unit dose packaging further fuels the demand for automation technologies in packaging. Therefore, the increasing prevalence of automation technologies in pharmaceutical packaging offers new growth opportunities in the market.
By Machine Type
In 2023, the filling machine segment accounted for the highest revenue share of the global market, which plays a crucial role in ensuring the precise and sterile dispensing of pharmaceutical products into various containers such as vials, bottles, and syringes.
Advanced filling machines utilize state-of-the-art technologies, including peristaltic pumps or volumetric fillers, to handle a diverse range of liquid or powder medications. These machines also feature automated controls and monitoring systems to enhance efficiency, reduce human error, and ensure compliance with pharmaceutical quality standards.
The flexibility of modern filling machines allows pharmaceutical companies to accommodate various container sizes and formulations, contributing to streamlined production processes and the delivery of high-quality, precisely dosed medications to meet the dynamic demands of the pharmaceutical industry. The integration of smart packaging technologies, such as RFID, QR codes, and sensors, has been rising, enabling real-time monitoring of pharmaceutical products throughout the supply chain and enhancing traceability and product quality.
Furthermore, the Association for Packaging and Processing Technologies reports that almost 50% of pharmaceutical companies have adopted automation integration in packaging, driven by the growth in small-batch pharmaceuticals and unit dose packaging. This increasing emergence of automation technologies in pharmaceutical packaging offers new growth opportunities in the market.
By End-User
The pharmaceutical companies segment is likely to hold the largest revenue share during the forecast period. These companies utilize the majority of pharmaceutical packaging equipment to ensure the safety and efficacy of their products. There is an expected significant surge in demand for packaging equipment in the coming years due to the increasing need for precise dosing and more efficient packing processes by pharmaceutical manufacturing businesses.
Regional Analysis
Asia-Pacific led the global pharmaceutical packaging equipment market revenue in 2023 and is projected to exhibit the fastest Compound Annual Growth Rate (CAGR) during the forecast period. This dominance is attributed to several key factors, including the region's rising population, escalating healthcare expenditures, and rapid technological advancements that significantly contribute to market expansion. The surge in the incidence of chronic diseases and infectious conditions in countries such as China, India, and Southeast Asian nations has increased the demand for medication, further driving the growth during the pharmaceutical packaging equipment market forecast.
The developing biopharmaceutical industry in Asia-Pacific, driven by increased healthcare spending and a rise in emphasis on novel therapeutic approaches, fuels the demand for pharmaceutical packaging equipment. Additionally, supportive government initiatives, collaborations between industry stakeholders, and strategic partnerships contribute to the expansion of the pharmaceutical packaging equipment market in the region, positioning Asia-Pacific as a significant region in the global healthcare and life sciences landscape. Thus, all the above factors contribute to the growth of the pharmaceutical packaging equipment market in this region.
Asia-Pacific offers profitable opportunities for key players operating in the pharmaceutical packaging equipment market, thereby registering the fastest growth rate during the forecast period, owing to the developments in healthcare infrastructure, the rise in manufacturing activities, as well as the well-established presence of domestic companies in the region. In addition, the surge in contract manufacturing organizations within the region provides a great opportunity for new entrants.
Key Companies Operating in the Global Pharmaceutical Packaging Equipment Market
Market Segmentation Outline
By Machine Type
By Formulation Type
By Automation Type
By End User
By Region
1 INTRODUCTION OF GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY MACHINE TYPE
5.1 OVERVIEW
5.2 FILLING MACHINES
5.3 FORM, FILL, AND SEAL MACHINES
5.4 CARTONING MACHINES
5.5 PALLETIZING MACHINES
5.6 LABELLING MACHINES
5.7 OTHERS
6 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY FORMULATION TYPE
6.1 OVERVIEW
6.2 LIQUID PACKAGING EQUIPMENT
6.3 SOLID PACKAGING EQUIPMENT
6.4 SEMISOLID PACKAGING EQUIPMENT
6.5 OTHERS
7 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY AUTOMATION TYPE
7.1 OVERVIEW
7.2 MANUAL
7.3 SEMI-AUTOMATIC
7.4 AUTOMATIC
8 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY END USER
8.1 OVERVIEW
8.2 PHARMACEUTICAL COMPANIES
8.3 CONTRACT MANUFACTURING COMPANIES
9 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL PHARMACEUTICAL PACKAGING EQUIPMENT MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 COMPETITIVE DASHBOARD
10.5 PRODUCT MAPPING
10.6 TOP PLAYER POSITIONING, 2022
10.7 COMPETITIVE HEATMAP
10.8 TOP WINNING STRATEGIES
11 COMPANY PROFILES
11.1 SYNTHETIC TECHNOLOGY
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.2 IMA S.P.A.
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.3 KÖRBER AG
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.4 UHLMANN GROUP
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.5 OPTIMA PACKAGING GROUP
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.6 ROMACO HOLDING
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.7 MG2 SRL
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.8 MARCHESINI GROUP
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.9 VANGUARD PHARMACEUTICAL MACHINERY
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.10 ACG WORLDWIDE
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 TRUSTAR PHARMA & PACKING EQUIPMENT
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 ACCUTEK PACKAGING EQUIPMENT COMPANIES
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 COESIA SPA
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 MULTIVAC GROUP
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 BUSCH MACHINERY
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 INLINE FILLING SYSTEMS
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 DARA PHARMACEUTICAL PACKAGING
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.18 DUKE TECHNOLOGIES
10.18.1 OVERVIEW
10.18.2 FINANCIAL PERFORMANCE
10.18.3 PRODUCT OUTLOOK
10.18.4 KEY DEVELOPMENTS
10.18.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.19 ARPAC LLC
10.19.1 OVERVIEW
10.19.2 FINANCIAL PERFORMANCE
10.19.3 PRODUCT OUTLOOK
10.19.4 KEY DEVELOPMENTS
10.19.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
著作権 ©2022 無断複写・転載を禁じます
